Peanut Allergy Pipeline Review and Therapeutics Development Market Research Report for H2 2015
PUNE, India, January 11, 2016 /PRNewswire/ --
ReportsnReports.com adds "Peanut Allergy - Pipeline Review, H2 2015" to its store. The report provides an overview of the Peanut Allergy's therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Peanut Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Peanut Allergy and special features on late-stage and discontinued projects. Complete report on H2 2015 pipeline review of Peanut Allergy with 22 market data tables and 15 figures, spread across 67 pages is available at http://www.reportsnreports.com/reports/453515-peanut-allergy-pipeline-review-h2-2015.html .
The report also reviews key players involved in the therapeutic development for Peanut Allergy and special features on late-stage and discontinued projects. Companies discussed in this Peanut Allergy - Pipeline Review, H2 2015 report include BioLingus AG, BioTech Tools s.a., DBV Technologies S.A., HAL Allergy BV and Immunomic Therapeutics, Inc.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Drug Profiles mentioned in this report are aldesleukin, Allergen for Peanut Allergy, AR-101, ARA-LAMP-Vax, DBV-712, DN-1017, Drugs to Inhibit CYP11A1 for Peanut Allergy and Asthma, Drugs to Inhibit PIM-1 Kinase for Respiratory and Immunological Diseases, PER-1080, pnut-ASIT, Recombinant Protein for Peanut Allergy, Recombinant Vector Vaccine for Peanut Allergy and VTC-064. Order a purchase copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=453515 . (This is a premium report priced at US$2000 for a single user License.)
Scope of this report: The report provides a snapshot of the global therapeutic landscape of Peanut Allergy and reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities with key players involved in the therapeutics development for Peanut Allergy and enlists all their major and minor projects. The report summarizes all the dormant and discontinued pipeline projects, review of the Peanut Allergy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages, a detailed assessment of monotherapy and combination therapy pipeline projects, coverage of the Peanut Allergy pipeline on the basis of target, MoA, route of administration and molecule type and latest news and deals relating related to pipeline products.
Another newly added report Pollen Allergy - Pipeline Review, H2 2015 provides comprehensive information on the therapeutic development for Pollen Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pollen Allergy and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Pollen Allergy Pipeline Review Research report of 108 pages is available at http://www.reportsnreports.com/reports/431354-pollen-allergy-pipeline-review-h2-2015.html .
Explore more reports on Pharmaceuticals industry at http://www.reportsnreports.com/market-research/pharmaceuticals/ .
About Us:
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
+ 1 888 391 5441
sales@reportsandreports.com
Connect With Us on:
Facebook: https://www.facebook.com/pages/ReportsnReports/191441427571689
LinkedIn: http://www.linkedin.com/company/reportsnreports
Twitter: https: //twitter.com/marketsreports
G+ / Google Plus: https://plus.google.com/111656568937629536321/posts
Pinterest: http://www.pinterest.com/comeonseo/reportsnreports/
RSS/Feeds: http: //http://www.reportsnreports.com/feed/l-latestreports.xml
Share this article